Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeek High Quality Obesity Management by ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic ... Previous studies have focused on the improvements in β-cell function, while the inhibition of α-cell secretion ...

GLP-1: Glucagon-like peptide-1 ... protecting cardiomyocytes from ischemic damage and improving contractile function in congestive heart failure. There is no current evidence that LA GLP1-RAs ...

Research has suggested that GLP-1 receptors in the brain may play a role in regulating mood and cognitive function, ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

However, as a mechano-gated ion channel, it should exert functions promptly. Is it possibly that piezo1 directly stimulates GLP-1 release by influx of Ca2+? if so, have authors measured intracellular ...

A Lancet study suggests that popular weight loss drugs could lead to muscle loss. Reserachers recommend combining these ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.